Local wound care and topical management of hidradenitis suppurativa - 14/10/15
Abstract |
Hidradenitis suppurativa (HS) is a chronic, recurrent, debilitating disease predominantly involving apocrine gland–bearing skin. The folliculoinfundibular dysfunction and an aberrant cutaneous immune response to commensal bacteria are recognized as potential contributors. Topical antibiotics, such as clindamycin, and keratolytic agents have been used in the management of early stages of HS. Proper wound care is a key part of management, particularly in patients with advanced HS. The evidence for the optimal topical therapy or optimal local wound care is limited. As such, a multidisciplinary approach is necessary to address all aspects of HS, including topical therapy, systemic therapy, and proper wound care. The focus of this paper is to review the evidence for the topical management and local wound care strategies in patients with HS.
Le texte complet de cet article est disponible en PDF.Key words : clindamycin, hidradenitis suppurativa, NPWT, resorcinol, retinoid, topical treatments
Plan
Disclosure: Dr Alavi is an advisor, consultant, and speaker for AbbVie and Janssen. She is an investigator for AbbVie and Novartis and received an unrestricted educational grant from AbbVie. Dr Kirsner declared no conflicts of interest. |
|
Conflicts of interest: None declared. |
Vol 73 - N° 5S1
P. S55-S61 - novembre 2015 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?